Lv4
470 积分 2024-02-05 加入
Inhibition of cap-dependent endonuclease in influenza virus with ADC189: a pre-clinical analysis and phase I trial
1天前
已完结
Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza
8天前
已完结
Comparison of High-Dose Versus Standard Dose Oseltamivir in Critically Ill Patients With Influenza
22天前
已完结
Onradivir: a novel influenza polymerase inhibitor
23天前
已完结
Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial
23天前
已完结
P-071 Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the U.S. Myeloma Immunotherapy Consortium
28天前
已完结
MM-1021: Efficacy and Safety of Less Frequent Dosing With Elranatamab (ELRA) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM): A US Subgroup Analysis From MagnetisMM-3
28天前
已完结
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
1个月前
已完结
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial
1个月前
已完结
Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma
1个月前
已完结
皖公网安备34019202002308
